• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病视网膜病变患者玻璃体切除术后玻璃体出血及复发性出血的危险因素分析。

Analysis of risk factors for vitreous hemorrhage and recurrent hemorrhage after vitrectomy in patients with diabetic retinopathy.

作者信息

Lu Shuwen, Li Haoyu, Ma Chao, Li Xian

机构信息

Department of Ophthalmology, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan, China.

Department of Ophthalmology, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, No. 19 Renmin Road, Zhengzhou, 450000, Henan, China.

出版信息

BMC Ophthalmol. 2025 May 7;25(1):274. doi: 10.1186/s12886-025-04112-w.

DOI:10.1186/s12886-025-04112-w
PMID:40335915
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12057211/
Abstract

PURPOSE

To investigate the risk factors associated with recurrent hemorrhage following vitrectomy surgical intervention for diabetic retinopathy (DR).

METHODS

A retrospective analysis was conducted on 579 eyes diagnosed with DR necessitating surgical intervention. These cases were categorized into two groups: recurrent hemorrhage and non-recurrent hemorrhage. Comparative, random forest (RF), and regression analyses were subsequently performed to evaluate variables pertaining to patients' demographic information, clinical examination and blood test results, treatment approaches, lifestyle habits, and overall health status.

RESULTS

This study compared patients with recurrent and non-recurrent hemorrhages, revealing significant differences in factors such as endodiathermy, anticoagulant use, cerebrovascular diseases, smoking status, glycosylated hemoglobin levels and BMI. Patients with no recurrent hemorrhage have faster vision recovery. The univariable logistic regression analysis indicated that cerebrovascular disease (OR = 7.87, P < 0.001), anticoagulant use (OR = 16.72, P < 0.001), and elevated glycated hemoglobin levels (OR = 21.22, P < 0.001) exhibited strong associations with recurrent hemorrhage. The multivariable logistic regression analysis indicated that recurrent hemorrhage risk factors include anticoagulant use (OR = 120.77, P = 0.020) and glycated hemoglobin levels (OR = 18.41, P = 0.001).

CONCLUSIONS

Recurrent postoperative hemorrhage is influenced by several factors, notably the use of intraoperative endodiathermy, adjustments in ocular therapy, and management of the patient's systemic condition. In clinical practice, careful consideration of these factors is essential to mitigate postoperative hemorrhage in patients.

摘要

目的

探讨糖尿病视网膜病变(DR)玻璃体切除手术干预后复发性出血的相关危险因素。

方法

对579例诊断为需要手术干预的DR患者的眼睛进行回顾性分析。这些病例分为两组:复发性出血组和非复发性出血组。随后进行比较分析、随机森林(RF)分析和回归分析,以评估与患者人口统计学信息、临床检查和血液检查结果、治疗方法、生活习惯及整体健康状况相关的变量。

结果

本研究比较了复发性出血和非复发性出血患者,发现内凝术、抗凝剂使用、脑血管疾病、吸烟状况、糖化血红蛋白水平和体重指数等因素存在显著差异。无复发性出血的患者视力恢复更快。单变量逻辑回归分析表明,脑血管疾病(OR = 7.87,P < 0.001)、抗凝剂使用(OR = 16.72,P < 0.001)和糖化血红蛋白水平升高(OR = 21.22,P < 0.001)与复发性出血密切相关。多变量逻辑回归分析表明,复发性出血的危险因素包括抗凝剂使用(OR = 120.77,P = 0.020)和糖化血红蛋白水平(OR = 18.41,P = 0.001)。

结论

术后复发性出血受多种因素影响,特别是术中内凝术的使用、眼部治疗的调整以及患者全身状况的管理。在临床实践中,仔细考虑这些因素对于减轻患者术后出血至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/127a/12057211/a8c6ae8dd25a/12886_2025_4112_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/127a/12057211/21b018d5294e/12886_2025_4112_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/127a/12057211/6ce16d81d209/12886_2025_4112_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/127a/12057211/a8c6ae8dd25a/12886_2025_4112_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/127a/12057211/21b018d5294e/12886_2025_4112_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/127a/12057211/6ce16d81d209/12886_2025_4112_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/127a/12057211/a8c6ae8dd25a/12886_2025_4112_Fig3_HTML.jpg

相似文献

1
Analysis of risk factors for vitreous hemorrhage and recurrent hemorrhage after vitrectomy in patients with diabetic retinopathy.糖尿病视网膜病变患者玻璃体切除术后玻璃体出血及复发性出血的危险因素分析。
BMC Ophthalmol. 2025 May 7;25(1):274. doi: 10.1186/s12886-025-04112-w.
2
Endodiathermy plus photocoagulation as treatment of sclerotomy site vascularization secondary to pars plana vitrectomy for proliferative diabetic retinopathy.内切开联合光凝治疗增殖性糖尿病视网膜病变行玻璃体切割术后巩膜切口血管化。
Retina. 2012 Jul;32(7):1310-5. doi: 10.1097/IAE.0b013e318236e7ef.
3
Characteristics of cases with postoperative vitreous hemorrhage after 25-gauge vitrectomy for repair of proliferative diabetic retinopathy.25G玻璃体切割术治疗增殖性糖尿病视网膜病变术后玻璃体出血病例的特征
Graefes Arch Clin Exp Ophthalmol. 2017 Apr;255(4):665-671. doi: 10.1007/s00417-016-3522-8. Epub 2016 Oct 21.
4
Preoperative hemoglobin A1c is associated with postoperative bleeding after vitrectomy for vitreous hemorrhage in patients with diabetic retinopathy.术前糖化血红蛋白水平与糖尿病视网膜病变患者玻璃体积血行玻璃体切除术后出血相关。
Endocr J. 2024 Oct 1;71(10):965-971. doi: 10.1507/endocrj.EJ23-0301. Epub 2024 Jun 26.
5
Visual outcomes and incidence of recurrent vitreous hemorrhage after vitrectomy in diabetic eyes pretreated with bevacizumab (avastin).经贝伐单抗(阿瓦斯汀)预处理的糖尿病性眼行玻璃体切除术后的视力预后及复发性玻璃体出血发生率
Retina. 2009 Jul-Aug;29(7):926-31. doi: 10.1097/IAE.0b013e3181a8eb88.
6
PERSISTENT OVERPRODUCTION OF INTRAOCULAR VASCULAR ENDOTHELIAL GROWTH FACTOR AS A CAUSE OF LATE VITREOUS HEMORRHAGE AFTER VITRECTOMY FOR PROLIFERATIVE DIABETIC RETINOPATHY.持续性眼内血管内皮生长因子过度产生作为增殖性糖尿病视网膜病变玻璃体切除术后晚期玻璃体出血的一个原因
Retina. 2017 Dec;37(12):2317-2325. doi: 10.1097/IAE.0000000000001490.
7
The effect of adjunctive intravitreal conbercept at the end of diabetic vitrectomy for the prevention of post-vitrectomy hemorrhage in patients with severe proliferative diabetic retinopathy: a prospective, randomized pilot study.糖尿病玻璃体切除术后联合应用康柏西普辅助治疗对预防严重增生性糖尿病视网膜病变患者术后出血的效果:一项前瞻性、随机试验研究。
BMC Ophthalmol. 2020 Feb 3;20(1):43. doi: 10.1186/s12886-020-1321-9.
8
Ultra-widefield fluorescein angiographic findings in patients with recurrent vitreous hemorrhage after diabetic vitrectomy.糖尿病玻璃体切除术后复发性玻璃体出血患者的超广角荧光素血管造影结果
Invest Ophthalmol Vis Sci. 2014 Oct 8;55(11):7040-6. doi: 10.1167/iovs.14-15112.
9
Risk Factors of Neovascular Glaucoma After 25-gauge Vitrectomy for Proliferative Diabetic Retinopathy with Vitreous Hemorrhage: A Retrospective Multicenter Study.增生型糖尿病视网膜病变伴玻璃体积血 25G 玻璃体切割术后新生血管性青光眼的危险因素:一项回顾性多中心研究。
Sci Rep. 2019 Oct 16;9(1):14858. doi: 10.1038/s41598-019-51411-6.
10
Intravitreal long-acting gas in the prevention of early postoperative vitreous hemorrhage in diabetic vitrectomy.玻璃体内长效气体在预防糖尿病性玻璃体切除术后早期玻璃体出血中的应用
Ophthalmology. 2007 Apr;114(4):710-5. doi: 10.1016/j.ophtha.2006.07.047. Epub 2007 Feb 2.

本文引用的文献

1
Submacular Hemorrhage Rates Following Anti-Vascular Endothelial Growth Factor Injections for Exudative Age-Related Macular Degeneration.抗血管内皮生长因子注射治疗渗出性年龄相关性黄斑变性后的黄斑下出血率
Am J Ophthalmol. 2025 Feb;270:172-182. doi: 10.1016/j.ajo.2024.10.017. Epub 2024 Oct 23.
2
Real-life neovascular AMD treatment considering reimbursement in Turkiye: One-year comparison of switching to intravitreal ranibizumab or aflibercept after treatment failure with three loading intravitreal bevacizumab injections.考虑到土耳其报销情况的真实世界新生血管性年龄相关性黄斑变性治疗:在三次负荷剂量玻璃体内注射贝伐单抗治疗失败后转换为玻璃体内注射雷珠单抗或阿柏西普的一年比较。
North Clin Istanb. 2024 Oct 3;11(5):451-459. doi: 10.14744/nci.2024.75688. eCollection 2024.
3
Investigation of the recurrent vitreous hemorrhage risk factors after early 25G vitrectomy in diabetic vitreous hemorrhage.糖尿病性玻璃体积血早期 25G 玻璃体切除术后再发性玻璃体积血的危险因素调查。
Medicine (Baltimore). 2024 Jan 19;103(3):e36963. doi: 10.1097/MD.0000000000036963.
4
Late postoperative vitreous cavity hemorrhage after vitrectomy for proliferative diabetic retinopathy-observation versus intervention.增生型糖尿病视网膜病变玻璃体切割术后晚期玻璃体积血:观察与干预。
Indian J Ophthalmol. 2024 Jan 1;72(Suppl 1):S22-S26. doi: 10.4103/IJO.IJO_311_23. Epub 2023 Dec 22.
5
Diabetic retinopathy in the pediatric population: Pathophysiology, screening, current and future treatments.儿童糖尿病视网膜病变:发病机制、筛查、现有及未来治疗方法。
Pharmacol Res. 2023 Feb;188:106670. doi: 10.1016/j.phrs.2023.106670. Epub 2023 Jan 18.
6
Diabetic retinopathy for the non-ophthalmologist.非眼科医生的糖尿病视网膜病变。
Clin Med (Lond). 2022 Mar;22(2):112-116. doi: 10.7861/clinmed.2021-0792.
7
Fibrinogen and Atherosclerotic Cardiovascular Diseases-Review of the Literature and Clinical Studies.纤维蛋白原与动脉粥样硬化性心血管疾病——文献综述和临床研究。
Int J Mol Sci. 2021 Dec 24;23(1):193. doi: 10.3390/ijms23010193.
8
Relationship between endothelin and nitric oxide pathways in the onset and maintenance of hypertension in children and adolescents.内皮素和一氧化氮通路在儿童和青少年高血压发病和维持中的关系。
Pediatr Nephrol. 2022 Mar;37(3):537-545. doi: 10.1007/s00467-021-05144-2. Epub 2021 Jun 3.
9
The value of glycosylated hemoglobin in the diagnosis of diabetic retinopathy: a systematic review and Meta-analysis.糖化血红蛋白在糖尿病视网膜病变诊断中的价值:系统评价和 Meta 分析。
BMC Endocr Disord. 2021 Apr 26;21(1):82. doi: 10.1186/s12902-021-00737-2.
10
Thirty-Year Trends in Complications in U.S. Adults With Newly Diagnosed Type 2 Diabetes.美国新诊断 2 型糖尿病成年人并发症 30 年趋势。
Diabetes Care. 2021 Mar;44(3):699-706. doi: 10.2337/dc20-2304. Epub 2021 Jan 8.